Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/
Create your
podcast in
minutes
It is Free